Bioartificial pancreas

Principles of Tissue Engineering, Third Edition

Volumn , Issue , 2007, Pages 619-633

  Sambanis, Athanassios ^a  

^a Georgia Institute of Technology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 65349148890     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012370615-7/50046-9     Document Type: Chapter

References (99)

1. D.L. Bigam and A.J. Shapiro (2004) Pancreatic transplantation: beta-cell replacement. Curr. Treat. Options Gastroenterol. 7 329-341
2. S.P. Black, I. Constantinidis, H. Cui, C. Tucker-Burden, C.J. Weber and S.A. Safley (2006) Immune responses to an encapsulated alloge-neic islet beta-cell line in diabetic NOD mice. Biochem. Biophys. Res. Commun. 340 236-243
3. K. Bloch, S. Assa, D. Lazard, N. Abramov, S. Shalitin, N. Weintrob, Z. Josefsberg, M. Rapoport and P. Vardi (1999) Neonatal pig islets induce a lower T-cell response than adult pig islets in IDDM patients. Transplantation 67 748-752
4. K. Bloch, E. Papismedov, K. Yavriyants, M. Vorobeychik, S. Beer and P. Vardi (2006) Photosynthetic oxygen generator for bioartificial pan-creas. Tissue Eng. 12 337-344
5. P. Blyszczuk, J. Czyz, G. Kania, M. Wagner, U. Roll, L. St-Onge and A.M. Wobus (2003) Expression of Pax4 in embryonic stem cells promotes differentiation of nestin-positive progenitor and insulin-producing cells. Proc. Natl. Acad. Sci. U.S.A. 100 998-1003
6. S. Bonner-Weir and A. Sharma (2002) Pancreatic stem cells. J. Pathol. 197 519-526
7. S. Bonner-Weir, M. Taneja, G.C. Weir, K. Tatarkiewicz, K.H. Song, A. Sharma and J.J. O'Neil (2000) In vitro cultivation of human islets from expanded ductal tissue. Proc. Natl. Acad. Sci. U.S.A. 97 7999-8004
8. J. Brauker, L.A. Martinson, R.S. Hill, S.K. Young, V.E. Carr-Brendel and R.C. Johnson (1992) Neovascularization of immunoisolation membranes: the effect of membrane architecture and encapsulated tissue. Transplant. Proc. 24 2924
9. J.H. Brauker, V.E. Carr-Brendel, L.A. Martinson, J. Crudele, W.D. Johnston and R.C. Johnson (1995) Neovascularization of synthetic membranes directed by membrane microarchitecture. J. Biomed. Mater. Res. 29 1517-1524
10. R. Calafiore, G. Basta, G. Luca, A. Lemmi, M.P. Montanucci, G. Calabrese, L. Racanicchi, F. Mancuso and P. Brunetti (2006) Microencapsulated pancreatic islet allografts into nonimmunosup-pressed patients with type 1 diabetes: first two cases. Diabetes Care 29 137-138
11. J.-Y. Cha, H. Kim, K.-S. Kim, M.-W. Hur and Y. Ahn (2000) Identification of transacting factors responsible for the tissue-specific expression of human glucose transporter type 2 isoform gene. J. Biol. Chem. 275 18358-18365
12. G. Chen, H.E. Hohmeier, R. Gasa, V.V. Tran and C.B. Newgard (2000) Selection of insulinoma cell lines with resistance to interleukin-1beta-and gamma-interferon-induced cytotoxicity. Diabetes 49 562-570
13. S.Y. Cheng, J. Gross and A. Sambanis (2004) Hybrid pancreatic tissue substitute consisting of recombinant insulin-secreting cells and glucose-responsive material. Biotechnol. Bioeng. 87 863-873
14. S.Y. Cheng, I. Constantinidis and A. Sambanis (2006) Use of glucose-responsive material to regulate insulin release from constitutively secreting cells. Biotechnol. Bioeng. 93 1079-1088
15. A.T. Cheung, B. Dayanandan, J.T. Lewis, G.S. Korbutt, R.V. Rajotte, M. Bryer-Ash, M.O. Boylan, M.M. Wolfe and T.J. Kieffer (2000) Glucose-dependent insulin release from genetically engineered K cells. Science 290 1959-1962
16. S.A. Clark, C. Quaade, H. Constandy, P. Hansen, P. Halban, S. Ferber, C.B. Newgard and K. Normington (1997) Novel insulinoma cell lines produced by iterative engineering of GLUT2, glucokinase, and human insulin expression. Diabetes 46 958-967
17. W. Creutzfeldt (1974) [Clinical significance of gastrointestinal hor-mones]. Verh. Dtsch. Ges. Inn. Med. 80 330-338
18. G.M. Cruise, O.D. Hegre, F.V. Lamberti, S.R. Hager, R. Hill, D.S. Scharp and J.A. Hubbell (1999) In vitro and in vivo performance of porcine islets encapsulated in interfacially photopolymerized poly (ethylene glycol) diacrylate membranes. Cell. Transplant. 8 293-306
19. C. Delaunay, S. Darquy, J. Honiger, F. Capron, C. Rouault and G. Reach (1998) Glucose-insulin kinetics of a bioartificial pancreas made of an AN69 hydrogel hollow fiber containing porcine islets and implanted in diabetic mice. Artif. Organs 22 291-299
20. D.J. Drucker (2002) Biological actions and therapeutic potential of the glucagon-like peptides. Gastroenterology 122 531-544
21. S. Efrat (1998) Cell-based therapy for insulin-dependent diabetes mel-litus. Eur. J. Endocrinol. 138 129-133
22. S. Efrat, S. Linde, H. Kofod, D. Spector, M. Delannoy, S. Grant, D. Hanahan and S. Baekkeskov (1988) Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene. Proc. Natl. Acad. Sci. U.S.A. 85 9037-9041
23. S. Efrat, M. Leiser, M. Surana, M. Tal, D. Fusco-Demane and N. Fleischer (1993) Murine insulinoma cell line with normal glucose-regulated insulin secretion. Diabetes 42 901-907
24. S. Efrat, D. Fusco-DeMane, H. Lemberg, E.O. al Emran O. and X. Wang (1995) Conditional transformation of apancreaticbeta-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene. Proc. Natl. Acad. Sci. U.S.A. 92 3576-3580
25. D.T. Finegood, L. Scaglia and S. Bonner-Weir (1995) Dynamics of beta-cell mass in the growing rat pancreas. Estimation with a simple mathematical model. Diabetes 44 249-256
26. J.D. Gross, I. Constantinidis and A. Sambanis (2007) Modeling of encapsulated cell systems. J. Theor. Biol. 244 500-510
27. K.A. Heald, N. Carless, T.R. Jay, N. Boucher and R. Downing (1999) Expression of the GALalpha (1–3) GAL epitope on pig islets. J. Mol. Med. 77 169-171
28. R.S. Hill, G.M. Cruise, S.R. Hager, F.V. Lamberti, X. Yu, C.L. Garufis, Y. Yu, K.E. Mundwiler, J.F. Cole, J.A. Hubbell, O.D. Hegre and D.W. Scharp (1997) Immunoisolation of adult porcine islets for the treatment of diabetes mellitus. The use of photopolymerizable polyethylene glycol in the conformal coating of mass-isolated porcine islets. Ann. N.Y. Acad. Sci. 831 332-343
29. S.D. Hughes, J.H. Johnson, C. Quaade and C.B. Newgard (1992) Engineering of glucose-stimulated insulin secretion and biosynthesis in non-islet cells. Proc. Natl. Acad. Sci. U.S.A. 89 688-692
30. S.D. Hughes, C. Quaade, J.H. Johnson, S. Ferber and C.B. Newgard (1993) Transfection of AtT-20ins cells with GLUT-2 but not GLUT-1 confers glucose-stimulated insulin secretion. Relationship to glucose metabolism. J. Biol. Chem. 268 15205-15212
31. H. Ikeda, N. Kobayashi, Y. Tanaka, S. Nakaji, C. Yong, T. Okitsu, M. Oshita, S. Matsumoto, H. Noguchi, M. Narushima, K. Tanaka, A. Miki, J.D. Rivas-Carrillo, A. Soto-Gutierrez, N. Navarro-Alvarez, K. Tanaka, H.S. Jun, N. Tanaka and J.W. Yoon (2006) A newly developed bioartificial pancreas successfully controls blood glucose in totally pancreatectomized diabetic pigs. Tissue Eng. 12 1799-1809
32. H.S. Jun and J.W. Yoon (2005) Approaches for the cure of type 1 dia-betes by cellular and gene therapy. Curr. Gene Ther. 5 249-262
33. T.J. Kieffer and J.F. Habener (1999) The glucagon-like peptides. Endocr. Rev. 20 876-913
34. D. Knaack, D.M. Fiore, M. Surana, M. Leiser, M. Laurance, D. Fusco-DeMane, O.D. Hegre, N. Fleischer and S. Efrat (1994) Clonal insulinoma cell line that stably maintains correct glucose responsive-ness. Diabetes 43 1413-1417
35. H. Kojima, M. Fujimiya, K. Matsumura, P. Younan, H. Imaeda, M. Maeda and L. Chan (2003) NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice. Nat. Med. 9 596-603
36. V.J. Lannoy, J.F. Decaux, C.E. Pierreux, F.P. Lemaigre and G.G. Rousseau (2002) Liver glucokinase gene expression is controlled by the onecut transcription factor hepatocyte nuclear factor-6. Diabetologia 45 1136-1141
37. R.P. Lanza, D.H. Butler, K.M. Borland, J.E. Staruk, D.L. Faustman, B.A. Solomon, T.E. Muller, R.G. Rupp, T. Maki, A.P. Monaco, et al. (1991) Xenotransplantation of canine, bovine, and porcine islets in diabetic rats without immunosuppression. Proc. Natl. Acad. Sci. U.S.A. 88 11100-11104
38. R.P. Lanza, S.J. Sullivan and W.L. Chick (1992) Perspectives in dia-betes. Islet transplantation with immunoisolation. Diabetes 41 1503-1510
39. R.P. Lanza, A.M. Beyer and W.L. Chick (1994) Xenogenic humoral responses to islets transplanted in biohybrid diffusion chambers. Transplantation 57 1371-1375
40. A. Lechner, A.L. Nolan, R.A. Blacken and J.F. Habener (2005) Redifferentiation of insulin-secreting cells after in vitro expansion of adult human pancreatic islet tissue. Biochem. Biophys. Res. Commun. 327 581-588
41. H.C. Lee, S.J. Kim, K.S. Kim, H.C. Shin and J.W. Yoon (2000) Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue. Nature 408 483-488
42. Y.-C. Lu, C. Sternini, E. Rozengurt and E. Zhokova (2005) Release of transgenic human insulin from gastric G cells: a novel approach for the amelioration of diabetes. Endocrinology 146 2610-2619
43. Z.P. Lum, M. Krestow, I.T. Tai, I. Vacek and A.M. Sun (1992) Xeno-grafts of rat islets into diabetic mice. An evaluation of new smaller capsules. Transplantation 53 1180-1183
44. N. Lumelsky, O. Blondel, P. Laeng, I. Velasco, R. Ravin and R. McKay (2001) Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 292 1389-1394
45. P. Lundberg and P.W. Kuchel (1997) Diffusion of solutes in agarose and alginate gels: 1H and 23Na PFGSE and 23Na TQF NMR studies. Magn. Reson. Med. 37 44-52
46. S.N. Mamujee, D. Zhou, M.B. Wheeler, I. Vacek and A.M. Sun (1997) Evaluation of immunoisolated insulin-secreting beta TC6-F7 cells as a bioartificial pancreas. Ann. Transplant. 2 27-32
47. M.H. May and M.V. Sefton (1999) Conformal coating of small particles and cell aggregates at a liquid-liquid interface. Ann. N Y. Acad. Sci. 875 126-134
48. A. Mikos, M. Papadaki, S. Kouvroukoglou, S. Ishaug and R. Thomson (1994) Mini-review: islet transplantation to create a bioartificial pan-creas. Biotechnol. Bioeng. 43 673-677
49. J. Miyazaki, K. Araki, E. Yamato, H. Ikegami, T. Asano, Y. Shibasaki, Y. Oka and K. Yamamura (1990) Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special refer-ence to expression of glucose transporter isoform. Endocrinology 127 126-132
50. H.P. Moore, M.D. Walker, F. Lee and R.B. Kelly (1983) Expressing a human proinsulin cDNA in a mouse ACTH-secreting cell. Intracellular storage, proteolytic processing, and secretion on stimulation. Cell 35 531-538
51. N. Mukherjee, Z. Chen, A. Sambanis and Y. Song (2005) Effects of cryopreservation on cell viability and insulin secretion in a model tissue-engineered pancreatic substitute (TEPS). Cell. Transplant. 14 449-456
52. M. Narushima, N. Kobayashi, T. Okitsu, Y. Tanaka, S.A. Li, Y. Chen, A. Miki, K. Tanaka, S. Nakaji, K. Takei, A.S. Gutierrez, J.D. Rivas-Carrillo, N. Navarro-Alvarez, H.S. Jun, K.A. Westerman, H. Noguchi, J.R. Lakey, P. Leboulch, N. Tanaka and J.W. Yoon (2005) A human beta-cell line for transplantation therapy to control type 1 diabetes. Nat. Biotechnol. 23 1274-1282
53. R.M. Nerem and A. Sambanis (1995) Tissue engineering: from biology to biological substitutes. Tissue Eng. 1 3-13
54. G.M. O'Shea, M.F. Goosen and A.M. Sun (1984) Prolonged survival of transplanted islets of Langerhans encapsulated in a biocompatible membrane. Biochim. Biophys. Acta 804 133-136
55. D.E. Olson, S.A. Paveglio, P.U. Huey, M.H. Porter and P.M. Thule (2003) Glucose-responsive hepatic insulin gene therapy of spontane-ously diabetic BB/Wor rats. Hum. Gene Ther. 14 1401-1413
56. L. Ouziel-Yahalom, M. Zalzman, L. Anker-Kitai, S. Knoller, Y. Bar, M. Glandt, K. Herold and S. Efrat (2006) Expansion and redifferentiation of adult human pancreatic islet cells. Biochem. Biophys. Res. Commun. 341 291-298
57. K.K. Papas, R.C. Long Jr., I. Constantinidis and A. Sambanis (1996) Effects of oxygen on metabolic and secretory activities of betaTC3 cells. Biochim. Biophys. Acta 1291 163-166
58. K.K. Papas, R.C. Long Jr., A. Sambanis and I. Constantinidis (1999) Development of a bioartificial pancreas: I. Long-term propagation and basal and induced secretion from entrapped betaTC3 cell cultures. Bio-technol. Bioeng. 66 219-230
59. K.K. Papas, R.C. Long Jr., A. Sambanis and I. Constantinidis (1999) Development of a bioartificial pancreas: II. Effects of oxygen on long-term entrapped betaTC3 cell cultures. Biotechnol. Bioeng. 66 231-237
60. A. Pileggi, R.D. Molano, C. Ricordi, E. Zahr, J. Collins, R. Valdes and L. Inverardi (2006) Reversal of diabetes by pancreatic islet transplanta-tion into a subcutaneous, neovascularized device. Transplantation 81 1318-1324
61. P. Prevost, S. Flori, C. Collier, E. Muscat and E. Rolland (1997) application of AN69 hydrogel to islet encapsulation. Evaluation in strepto-zotocin-induced diabetic rat model. Ann. N.Y. Acad. Sci. 831 344-349
62. A. Prokop (2001) Bioartificial pancreas: materials, devices, function, and limitations. Diabetes Technol. Ther. 3 431-449
63. A. Prokop, E. Kozlov, N.S. Nun Non S., M.M. Dikov, G.C. Sephel, J.S. Whitsitt and J.M. Davidson (2001) Towards retrievable vascularized bio-artificial pancreas: induction and long-lasting stability of polymeric mesh implant vascularized with the help of acidic basic fibroblast growth factors and hydrogel coating. Diabetes Technol. Ther. 3 245-261
64. J. Rajagopal, W.J. Anderson, S. Kume, O.I. Martinez and D.A. Melton (2003) Insulin staining of ES cell progeny from insulin uptake. Science 299 363
65. V.K. Ramiya, M. Maraist, K.E. Arfors, D.A. Schatz, A.B. Peck and J.G. Cornelius (2000) Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Nat. Med. 6 278-282
66. G.R. Rayat, R.V. Rajotte, J.F. Elliott and G.S. Korbutt (1998) Expression of Gal alpha (1,3) gal on neonatal porcine islet beta-cells and susceptibility to human antibody/complement lysis. Diabetes 47 1406-1411
67. T. Sakurai, A. Satake, N. Nagata, Y. Gu, A. Hiura, K. Doo-Hoon, H. Hori, Y. Tabata, S. Sumi and K. Inoue (2003) The development of new immunoisolatory devices possessing the ability to induce neovascular-ization. Cell Transplant. 12 527-535
68. A. Sambanis (2000) Engineering challenges in the development of an encapsulated cell system for treatment of type 1 diabetes. Diabetes Technol. Therap. 2 81-89
69. A. Sambanis and S.A. Tan (1999) Quantitative modeling of limitations caused by diffusion. J.R. Morgan, M.L. Yarmush (Eds) Methods in Molecular Medicine, Vol. 18: Tissue Engineering Methods and Protocols Totowa, NJ: Humana Press
70. A. Sambanis, G. Stephanopoulos, A.J. Sinskey and H.F. Lodish (1990) Use of regulated secretion in protein production from animal cells: an evaluation with the AtT-20 model cell line. Biotechnol. Bioeng. 35 771-780
71. A. Sambanis, S.-C. Tang, S.-Y. Cheng, C.L. Stabler, R.C.J. Long and I. Constantinidis (2002) Core technologies in tissue engineering and their application to the bioartificial pancreas. Y. Ikada, Y. Umakoshi, T. Hotta (Eds) Tissue Engineering for Therapeutic Use Boston: Elsevier 5-18
72. J. Schirra, M. Katschinski, C. Weidmann, T. Schafer, U. Wank, R. Arnold and B. Goke (1996) Gastric emptying and release of incretin hor-mones after glucose ingestion in humans. J. Clin. Invest. 97 92-103
73. M. Sefton and L. Kharlip (1994) Insulin release from rat pancreatic islets microencapsulated in a HEMA-MMA polyacrylate. R. Lanza, W. Chick (Eds) Pancreatic Islet Transplantation. Volume III: Immunoisolation of Pancreatic Islets Georgetown, TX: RG Landes
74. M.V. Sefton, M.H. May, S. Lahooti and J.E. Babensee (2000) Making microencapsulation work: conformal coating, immobilization gels and in vivo performance. J. Controlled Release 65 173-186
75. A.M. Shapiro, E.A. Ryan and J.R. Lakey (2001) Clinical islet trans-plant—state of the art. Transplant. Proc. 33 3502-3503
76. A.M. Shapiro, E.A. Ryan and J.R. Lakey (2001) Diabetes. Islet cell transplantation. Lancet 358 S2-S21. (Suppl)
77. A.M. Shapiro, E.A. Ryan and J.R. Lakey (2001) Pancreatic islet transplantation in the treatment of diabetes mellitus. Best Pract. Res. Clin. Endocrinol. Metab. 15 241-264
78. N.E. Simpson, N. Khokhlova, J.A. Oca-Cossio, S.S. McFarlane, C.P. Simpson and I. Constantinidis (2005) Effects of growth regulation on conditionally transformed alginate-entrapped insulin secreting cell lines in vitro. Biomaterials 26 4633-4641
79. Y.C. Song, Z.Z. Chen, N. Mukherjee, F.G. Lightfoot, M.J. Taylor, K.G. Brockbank and A. Sambanis (2005) Vitrification of tissue-engineered pancreatic substitute. Transplant. Proc. 37 253-255
80. P. Soon-Shiong, E. Feldman, R. Nelson, R. Heintz, N. Merideth, P. Sandford, T. Zheng and J. Komtebedde (1992) Long-term reversal of diabetes in the large animal model by encapsulated islet transplanta-tion. Transplant. Proc. 24 2946-2947
81. P. Soon-Shiong, R.E. Heintz, N. Merideth, Q.X. Yao, Z. Yao, T. Zheng, M. Murphy, M.K. Moloney, M. Schmehl, M. Harris, et al. (1994) Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet 343 950-951
82. B. Soria, E. Roche, G. Berna, T. Leon-Quinto, J.A. Reig and F. Martin (2000) Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes 49 157-162
83. C. Stabler, K. Wilks, A. Sambanis and I. Constantinidis (2001) The effects of alginate composition on encapsulated betaTC3 cells. Bio-materials 22 1301-1310
84. C.L. Stabler, R.C. Long Jr., I. Constantinidis and A. Sambanis (2005) In vivo noninvasive monitoring of a tissue-engineered construct using 1H-NMR spectroscopy. Cell. Transplant. 14 139-149
85. S.J. Sullivan, T. Maki, K.M. Borland, M.D. Mahoney, B.A. Solomon, T.E. Muller, A.P. Monaco and W.L. Chick (1991) Biohybrid artificial pancreas: long-term implantation studies in diabetic, pancreatecto-mized dogs. Science 252 718-721
86. A.M. Sun, I. Vacek, Y.L. Sun, X. Ma and D. Zhou (1992) In vitro and in vivo evaluation of microencapsulated porcine islets. Asaio J. 38 125-127
87. S.-C. Tang and A. Sambanis (2003) Preproinsulin mRNA engineering and its application to the regulation of insulin secretion from human hepatomas. FEBS Lett. 537 193-197
88. S.C. Tang and A. Sambanis (2003) Development of genetically engineered human intestinal cells for regulated insulin secretion using rAAV-mediated gene transfer. Biochem. Biophys. Res. Commun. 303 645-652
89. S.C. Tang and A. Sambanis (2004) Differential rAAV2 transduction efficiencies and insulin secretion profiles in pure and coculture models of human enteroendocrine L-cells and enterocytes. J. Gene Med. 6 1003-1013
90. P.M. Thule and J.M. Liu (2000) Regulated hepatic insulin gene therapy of STZ-diabetic rats. Gene Ther. 7 1744-1752
91. P.M. Thule, J. Liu and L.S. Phillips (2000) Glucose-regulated produc-tion of human insulin in rat hepatocytes. Gene Ther. 7 205-214
92. P.M. Thule, A.G. Campbell, D.J. Kleinhenz, D.E. Olson, J.J. Boutwell, R.L. Sutliff and C.M. Hart (2006) Hepatic insulin gene therapy prevents deterioration of vascular function and improves adi-pocytokine profile in STZ-diabetic rats. Am. J. Physiol. Endocrinol. Metab. 290 E114-E122
93. I. Todorov, K. Omori, M. Pascual, J. Rawson, I. Nair, L. Valiente, T. Vuong, T. Matsuda, C. Orr, K. Ferreri, C.V. Smith, F. Kandeel and Y. Mullen (2006) Generation of human islets through expansion and differentiation of non-islet pancreatic cells discarded (pancreatic discard) after islet isolation. Pancreas 32 130-138
94. E. Tziampazis and A. Sambanis (1995) Tissue engineering of a bio-artificial pancreas: modeling the cell environment and device func-tion. Biotechnol. Prog. 11 115-126
95. S. Wang, J. Liu, L. Li and B.M. Wice (2004) Individual subtypes of enteroendocrine cells in the mouse small intestine exhibit unique pat-terns of inositol 1,4,5-trisphosphate receptor expression. J. Histochem. Cytochem. 52 53-63
96. F. Wiegand, K.D. Kroncke and V. Kolb-Bachofen (1993) Macro-phage-generated nitric oxide as cytotoxic factor in destruction of alginate-encapsulated islets. Protection by arginine analogs and/or coencapsulated e. Transplantation 56 1206-1212
97. H. Wu, E.S. Avgoustiniatos, L. Swette, S. Bonner-Weir, G.C. Weir and C.K. Colton (1999) In situ electrochemical oxygen generation with an immunoisolation device. Ann. N.Y. Acad. Sci. 875 105-125
98. M. Yanagita, K. Nakayama and T. Takeuchi (1992) Processing of mutated proinsulin with tetrabasic cleavage sites to bioactive insulin in the nonendocrine cell line, COS-7. FEBS Lett. 311 55-59
99. M. Yanagita, H. Hoshino, K. Nakayama and T. Takeuchi (1993) Processing of mutated proinsulin with tetrabasic cleavage sites to mature insulin reflects the expression of furin in nonendocrine cell lines. Endo-crinology 133 639-644